July 23, 2026

Press Release: Proactive support to quit tobacco use during cancer treatment doubles quit rates in a nationwide trial

July 15, 2026

Press Release: ECOG-ACRIN ENDURANCE trial findings published in the New England Journal of Medicine provide the first randomized evidence on the optimal duration of lenalidomide maintenance for patients with newly diagnosed multiple myeloma

June 10, 2026

Press Release: Elsa Anagnostou, Jordan Berlin, and Olisaemeka Ogbue receive ECOG-ACRIN 2026 scientific leadership and mentorship awards

May 28, 2026

The May 2026 News from ECOG-ACRIN blog is now available

May 19, 2026

Press Release: TAILORx and RxPONDER trials shift to a discovery platform for analyzing breast cancer recurrence using advanced tumor profiling and AI

May 15, 2026

The Spring 2026 advocacy blog Considering Clinical Trials is now available

April 27, 2026

The April 2026 News from ECOG-ACRIN blog is now available

March 19, 2026

Press Release: ECOG-ACRIN completes enrollment for 600-patient clinical trial focused on frontline treatment for advanced melanoma

March 4, 2026

Press Release: ECOG-ACRIN Cancer Research Group announces the retirement of Robert Gray after 25 years as group statistician

ECOG-ACRIN Cancer Research Group